- Report
- January 2024
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- January 2018
- 134 Pages
Global
From €2883EUR$3,000USD£2,479GBP
- Report
- November 2020
- 75 Pages
Asia Pacific
From €1441EUR$1,500USD£1,239GBP
- Report
- September 2022
- 35 Pages
Global
- Report
- February 2018
- 382 Pages
Global
From €3891EUR$4,050USD£3,346GBP
- Book
- May 2023
- 768 Pages
- Book
- April 2023
- 384 Pages
- Book
- March 2023
- 208 Pages
- Book
- July 2022
- 624 Pages
- Book
- July 2022
- 432 Pages
- Book
- June 2022
- 592 Pages
- Book
- May 2022
- 160 Pages
- Book
- March 2021
- 208 Pages
- Book
- February 2021
- 656 Pages
- Book
- October 2020
- 752 Pages
- Book
- October 2020
- 240 Pages
- Book
- September 2020
- 288 Pages
- Book
- March 2020
- 560 Pages
Global
- Book
- April 2019
- 200 Pages
- Book
- February 2015
- 296 Pages
Sepsis is a life-threatening medical condition caused by the body's response to an infection. It is a major cause of death and disability in healthcare services, and is estimated to affect more than 30 million people worldwide each year. Sepsis is a complex condition that requires early diagnosis and prompt treatment to reduce the risk of death and long-term disability. Healthcare services are increasingly focusing on early detection and treatment of sepsis, as well as prevention strategies.
The sepsis market is composed of a range of products and services, including diagnostics, therapeutics, and monitoring devices. Diagnostics include laboratory tests, imaging, and biomarkers, while therapeutics include antibiotics, immunomodulators, and supportive care. Monitoring devices include pulse oximeters, blood pressure monitors, and other vital sign monitors.
Companies in the sepsis market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Philips Healthcare. Show Less Read more